Old Second Bancorp Inc. (OSBC): News on big money folks dumping the mark...

News on big money folks dumping the market

Johnny4profits · 2013-07-30T14:48:45.4000000Z

News on big money folks dumping the market hit the waves yesterday. Most likely had an impact on OSBC. Maybe just conjecture, but it fits.

Play Episode

6min

Proactive - Interviews for investors

FDA approval sees Orthocell’s Remplir enter multi-billion dollar US nerve market

Orthocell Ltd chairman John van der Wielen talked with Proactive about the company receiving FDA clearance for its nerve repair product, Remplir, paving the way for entry into the multi-billion US healthcare market. The approval marks a significant milestone in Orthocell’s international growth strategy and reflects the strength of its regulatory and clinical capabilities. Van der Wielen emphasised the significance of breaking into the US market in a challenging regulatory environment. “Not many people would have thought with the current US turmoil, a company like ours could achieve FDA clearance,” he said. Orthocell has established operations in the US with logistics and distribution already in place. The company is implementing a hybrid sales model using in-house personnel and regional distributors, aiming for rapid initial uptake with an eye on more exclusive arrangements in the future. Remplir’s three-year shelf life and no temperature control requirement make it ideal for streamlined deployment. He also highlighted that Orthocell has already performed over 2,000 procedures in Australia and anticipates the US market to be 20 to 30 times larger, creating a strong revenue opportunity. With $32 million in cash reserves, the company expects to become cash flow positive within two years. 👉 For more interviews and updates, head to Proactive’s YouTube channel. Don’t forget to like the video, subscribe, and turn on notifications. #Orthocell #FDAApproval #Remplir #NerveRepair #MedicalDevices #BiotechNews #USHealthcare #OrthocellRemplir #InvestorUpdate #ProactiveInvestors #SurgicalInnovation #ASX

Proactive - Interviews for investors

Team Internet CEO highlights strategic momentum across Domains, Comparison, and Search divisions

Team Internet CEO Michael Riedl joined Steve Darling from Proactive’s OTC studio in New York City to update the company’s strategic progress across its three core business segments: domains, comparison, and search. Each division, Riedl explained, is navigating a distinct phase of growth, underpinned by a clear long-term vision and strong operational execution. In the domains division, Team Internet continues to serve as a trusted partner to some of the world’s leading web hosting and cybersecurity providers. The company’s expertise in securing and managing global online identities remains a foundational strength, supporting businesses as they establish and protect their digital presence in an increasingly interconnected world. The comparison segment has seen exceptional performance in 2024, with over 40% organic growth year-to-date. Profitability in this division has also surged, with profits increasing by an impressive 75%. This momentum reflects strong consumer demand, effective execution, and the scalability of Team Internet’s comparison platforms. Looking ahead, the company has set its sights on international expansion, with plans to take its successful comparison model beyond Germany into new high-potential markets. Riedl also shared insights into the ongoing transformation of the search business, which is transitioning from the legacy AdSense for Domains model to a more advanced offering known as "Related Search on Content." While the shift presents transitional challenges, the new model is already gaining traction. “Even though this transition gives us some challenges, as demonstrated by our recent reforecast, this business is really going very well,” Riedl noted. He highlighted that the search division is now scaling rapidly, adding nearly $10 million in annual recurring revenue (ARR) every week—a clear signal of its growth potential and strategic importance. The U.S. market continues to play a central role in Team Internet’s overall strategy, currently

Proactive - Interviews for investors

Pluri CEO Yaky Yanay on pioneering cell-tech solutions for global needs

Pluri Inc. (NASDAQ:PLUR) CEO Yaky Yanay joined Proactive's Stephen Gunnion with more about the company’s progress in developing and commercializing its cell-based technology platform, highlighting recent partnerships, strategic financing, and future milestones. Pluri is a biotechnology company focused on manufacturing products derived from cells—including human, animal, and plant cells—for applications across industries such as healthcare, food, and agriculture. "We are taking this tiny organism, cells... and we create products out of them," Yanay explained. A key highlight was Pluri’s collaboration with Hemafund in Ukraine to enhance the country’s preparedness for radiation emergencies. Yanay detailed the use of PLX-R18, a placenta-based therapeutic developed with US federal agencies, which has shown potential to significantly improve survival rates following radiation exposure. The discussion also covered Pluri’s recent financing activities, including a $10 million raise and the acquisition of cacao company Kokomodo. These moves are part of Pluri’s broader expansion into the food sector, addressing shortages in coffee and cacao through cell cultivation in bioreactors. Looking ahead, Yanay emphasized a strong pipeline of deals for 2025, with a focus on sustainable, cell-based solutions for some of humanity’s biggest needs. For more interviews and updates, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for future content. #PluriInc #BiotechInnovation #CellTherapy #SustainableTech #RadiationPreparedness #CoffeeCrisis #CacaoShortage #HealthcareTech #InvestmentNews #YakyYanay #ProactiveInvestors

Proactive - Interviews for investors

Novo Resources targets gold at Tibooburra

Novo Resources Corp executive co-chair Mike Spreadborough and exploration manager Kas De Luca talked with Proactive about the company’s current exploration, strategy and key drilling campaigns underway in 2025. Spreadborough detailed the company's focus on standalone projects with the potential to exceed one million ounces, with current efforts centred on drilling programs at the Balla Balla project, Tibooburra Gold Project, and upcoming activity at the John Bull Project. “We’re not chasing brownfields mill feed for an existing processing plant. We’re looking for something new and exciting,” he said. De Luca shared insights into the Clone prospect at Tibooburra, highlighting its strong geological context and mineralisation indicators. “The clone thrust has been really identified and pinpointed now as a foot wall shear zone… that seems to us both in the drilling and in service to carry most of the mineralisation,” she noted. De Luca said results from surface sampling returned grades up to 89 grams per tonne, and the company has only tested a small fraction of a 60km mineralised trend. Novo expects results from three programs between now and July and continues to assess additional farm-in opportunities as part of its strategy. For more videos from Proactive, give this video a like, subscribe to our channel, and turn on notifications so you never miss an update. #GoldExploration #NovoResources #TibooburraGold #GreenfieldsExploration #JuniorMining #RCDrilling #GoldStocks #AustralianMining #MiningUpdates #ProactiveInvestors

Followers	321
Posts	17930
Boards Moderated	0
Alias Born	04/24/2009

Volume:	105,972
Day Range:	14.21 - 15.22
Bid:	14.53
Ask:	14.56
Last Trade Time:	2:27:38 PM EDT
Total Trades:	3,103

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

OSBC Detailed Quote

Recent OSBC News

More OSBC News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent OSBC News

Go Ad-Free